LifeStance Health

LifeStance Health is an American behavioral-health services company established in 2015. It operates an outpatient care platform that connects patients with licensed mental-health professionals through both physical clinics and telehealth appointments. Its services include psychotherapy, psychiatry, transcranial magnetic stimulation (TMS), and ketamine-related therapies. The company’s model is designed to combine a geographically distributed clinic network with centralized operational, administrative, and technology support for clinicians. The business expanded through a combination of organic growth and acquisitions. A significant ownership and capital event occurred in April 2020, when private-equity firm TPG acquired LifeStance for approximately $1.2 billion in equity, according to the referenced account of the company’s history. Summit Partners and Silversmith Capital Partners were also associated with the company’s private-equity ownership. In 2021, LifeStance acquired Acquity Counseling, a Seattle-based behavioral-health provider with seven locations, adding to its regional footprint. LifeStance became a public company on June 10, 2021. The initial public offering raised approximately $720 million, while TPG and other financial sponsors retained a substantial ownership position after the offering. The company’s public-market period has been characterized by efforts to expand access to mental-health treatment, invest in its provider platform, and subsequently consolidate parts of its clinic network. The company has promoted a hybrid delivery model in which patients can receive care in person or remotely. Telehealth has become a particularly important component of its appointment volume: the referenced material states that more than 70% of appointments were delivered through telehealth. By 2024, LifeStance reported approximately 7,400 licensed mental-health clinicians and operated in-person services from 569 locations across 33 U.S. states. During 2023, it closed 82 clinics while opening 35, a pattern described as a consolidation effort rather than a simple expansion program. LifeStance has also used public-awareness activity to frame mental health as a broad social issue. Its 2021 Not1Face campaign sought to draw attention to the mental-health crisis in the United States and to challenge stigmatizing or overly narrow portrayals of people experiencing mental-health conditions. The company has faced legal and reputational challenges. Former employees filed two lawsuits in 2023 alleging that the company’s use of salary advances and repayment requirements imposed on some clinicians violated labor law and amounted to coercive employment practices. In 2024, LifeStance paid $50 million to settle a shareholder lawsuit alleging that it had misled investors about clinician-retention rates; the settlement did not establish the allegations as proven facts. Hindenburg Research subsequently published a critical report that also focused on clinician retention. As of January 2025, the company was reported to be facing a proposed class action alleging that patient information had been shared with Meta Platforms without consent. These disputes, together with scrutiny of clinician economics and retention, have been important parts of the brand’s public profile.

LifeStance Health was founded in 2015 as a provider focused on outpatient behavioral-health services. Its operating concept combines clinicians, physical offices, and digital appointment infrastructure so that patients can access therapy and psychiatric care either in person or remotely. The company’s service portfolio also includes specialized modalities such as transcranial magnetic stimulation and ketamine therapies. The company entered a major phase of institutional ownership in April 2020, when TPG acquired it in a transaction reported at approximately $1.2 billion in equity. Summit Partners and Silversmith Capital Partners were also associated with the company’s private-equity ownership. The investment provided a platform for further growth and preparation for the public markets. In 2021, LifeStance acquired Acquity Counseling, a Seattle-based provider with seven locations. That acquisition expanded the company’s clinic presence and fit its broader strategy of assembling a multi-state behavioral-health network. LifeStance also launched the Not1Face campaign in 2021. The campaign addressed the mental-health crisis and promoted a less stereotyped understanding of people who seek mental-health support. LifeStance completed its initial public offering on June 10, 2021, raising approximately $720 million. After the offering, TPG and other private-equity investors retained a substantial combined ownership position. The public-company period brought increased attention to the economics of outpatient behavioral health, including clinician recruitment, productivity expectations, retention, reimbursement, and the balance between physical clinics and telehealth. Ken Burdick served as chief executive officer from 2022 until 2025. The company’s reported footprint as of 2024 included approximately 7,400 licensed mental-health clinicians and 569 in-person locations across 33 states. Telehealth accounted for more than 70% of appointments according to the referenced material. At the same time, LifeStance pursued consolidation: during 2023 it closed 82 clinics and opened 35, indicating a focus on reshaping the network rather than maximizing the raw number of locations. Financial and operational performance remained under scrutiny. LifeStance reported a net loss of $187 million for 2023, described as a 12% reduction in the size of its loss compared with 2022. Investor and media attention also centered on clinician retention. In 2023, 15 former employees brought two lawsuits alleging that certain salary-advance and repayment arrangements violated labor laws and created coercive employment conditions. In 2024, the company paid $50 million to settle shareholder litigation alleging that investors had been misled about clinician-retention rates. Hindenburg Research later issued a critical report making related claims; those allegations were contested matters rather than established findings in the supplied material. In January 2025, LifeStance was reported to be facing a proposed class action concerning alleged disclosure of patient information to Meta Platforms without consent. On February 27, 2025, the company announced that Dave Bourdon would become chief executive officer, replacing Burdick. LifeStance therefore entered its latest phase as a large U.S. outpatient behavioral-health platform balancing virtual delivery, clinic-network optimization, specialized treatment offerings, and legal and reputational scrutiny.

• 2025

  CEO transition

  [1]Lifestance Healthen.wikipedia.org

  LifeStance announced that Dave Bourdon would replace Ken Burdick as chief executive officer.

• 2023

  Clinic consolidation and reported annual loss

  [1]Lifestance Healthen.wikipedia.org

  The company closed 82 clinics and opened 35 during a consolidation effort; its reported net loss was $187 million for the year.

• 2021

  Acquity Counseling acquired

  [1]Lifestance Healthen.wikipedia.org

  LifeStance acquired Seattle-based Acquity Counseling, which operated seven locations.

• 2021

  Initial public offering

  [1]Lifestance Healthen.wikipedia.org

  LifeStance became publicly listed and raised approximately $720 million through its IPO.

• 2021

  Not1Face campaign launched

  [1]Lifestance Healthen.wikipedia.org

  The company launched Not1Face to address the U.S. mental-health crisis and broaden public understanding of mental-health experiences.

• 2020

  TPG acquisition

  [1]Lifestance Healthen.wikipedia.org

  TPG acquired LifeStance in a transaction reported at approximately $1.2 billion in equity.

• 2015

  Company founded

  [1]Lifestance Healthen.wikipedia.org

  LifeStance Health was established as an outpatient behavioral-health services provider.

A scaled, technology-enabled outpatient behavioral-health provider combining a national clinic network with virtual access and multiple forms of therapy and psychiatric care.

• Therapy

  Psychotherapy

  LifeStance provides outpatient psychotherapy through licensed clinicians in offices and through telehealth. The offering forms a core part of the company’s behavioral-health platform and is intended to give patients a choice between scheduled in-person appointments and remote sessions.

• Medical behavioral-health care

  Psychiatry

  Psychiatric services include evaluation and ongoing care delivered by psychiatric professionals. Depending on the clinician and patient’s needs, care may involve medication management and may be provided at a physical location or through the company’s telehealth channel.

• Digital healthcare delivery

  Telehealth

  Telehealth is a central delivery channel for LifeStance’s therapy and psychiatry services. The supplied reference material states that virtual appointments represented more than 70% of the company’s appointment volume, making remote access a defining feature of its operating model.

• Specialized mental-health treatment

  Transcranial magnetic stimulation

  LifeStance lists transcranial magnetic stimulation, commonly abbreviated TMS, among its specialized behavioral-health therapies. It is offered as part of the company’s broader outpatient service portfolio rather than as a standalone consumer product.

• Specialized mental-health treatment

  Ketamine therapies

  Ketamine therapies are included among LifeStance’s treatment offerings. The supplied material does not specify the exact protocols, locations, indications, or product names used by the company, so this entry is limited to identifying the service category.

• 2025

  Alleged sharing of patient information with Meta

  The company was reported to face a proposed class action alleging that patient personal information was shared with Meta Platforms without consent.

  Source

• 2024

  Shareholder lawsuit settlement over clinician retention

  LifeStance paid $50 million to settle shareholder claims alleging that the company misled investors about clinician-retention rates. The settlement resolved the litigation without the supplied material establishing the allegations as proven.

  Source

• 2023

  Former employees allege unlawful labor practices

  Two lawsuits filed by 15 former employees alleged that salary advances and repayment obligations connected to productivity standards violated labor laws and created coercive employment conditions. The supplied material reports allegations, not a final adjudication.

  Source

Read more

• 2021Not1Face

  United States

  LifeStance launched Not1Face as a public-awareness effort focused on the U.S. mental-health crisis and on challenging simplistic representations of people experiencing mental-health conditions.

  Source

• 2025

  Change chief executive officerStrategy

  Background

  LifeStance announced a leadership transition after Ken Burdick had served as chief executive since 2022.

  Action taken

  Dave Bourdon was named to succeed Burdick as chief executive officer.

  Source

• 2023

  Consolidate clinic networkStrategy

  Background

  LifeStance adjusted its physical footprint while telehealth represented a large share of appointments.

  Action taken

  The company closed 82 clinics and opened 35 during the year.

  Aftermath

  The activity was characterized as consolidation and contributed to a more selective physical-network strategy.

  Source

• 2021

  Acquire Acquity CounselingM&A

  Background

  LifeStance sought to enlarge its regional outpatient behavioral-health network.

  Action taken

  The company acquired Seattle-based Acquity Counseling, which had seven locations.

  Aftermath

  The acquisition added physical locations to LifeStance’s developing multi-state platform.

  Source

• 2021

  Complete initial public offeringOther

  Background

  The company pursued public-market financing after its private-equity-backed expansion.

  Action taken

  LifeStance completed its IPO and raised approximately $720 million.

  Aftermath

  The company became publicly traded while existing financial sponsors retained substantial ownership.

  IPO proceeds. $720 million (June 10, 2021)

  Source

• 2020

  Accept private-equity acquisition by TPGM&A

  Background

  LifeStance entered a major institutional-ownership phase as it expanded its outpatient behavioral-health platform.

  Action taken

  TPG acquired the company in an equity transaction reported at approximately $1.2 billion.

  Aftermath

  The transaction preceded LifeStance’s 2021 public offering, after which TPG and other sponsors retained a substantial ownership position.

  Reported equity transaction value. $1.2 billion (April 2020)

  Source

1. 1Lifestance Healthen.wikipedia.org